SGSelvaraj Giridharan

Selvaraj Giridharan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Selvaraj Giridharan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Isha Yoga Practices on Health Outcomes: A Systematic Review of Controlled Studies

    by Selvaraj Giridharan, Bhuvana Pandiyan, Nagaraj V. Kumar, Mrunmai Godbole, Soni Soumian, Nagaraj V. Kumar Sr.

    The global burden of chronic diseases and mental health disorders has intensified the need for holistic interventions such as yoga. Isha Yoga, a comprehensive system integrating physical postures, breathwork, and meditation, has demonstrated preliminary benefits in stress reduction and physiological regulation. This systematic review evaluates the effects of Isha Yoga practices on mental and physical health outcomes in controlled studies. In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, systematic searches were conducted in PubMed, Scopus, Web of Science, and the Cochrane Library from database inception to July 2025. Eligible studies employed controlled designs, including randomised controlled trials (RCTs), non-randomised controlled studies, and cross-sectional comparative studies that evaluated the effects of Isha Yoga practices on health-related outcomes with comparators. Methodological quality and risk of bias were assessed using the Cochrane Risk of Bias 2 tool for RCTs and the Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) tool for non-randomised studies. Due to heterogeneity, a narrative synthesis was performed, grouped by outcomes with subgroups for expertise and dosage. Nine studies were included: three RCTs, four non-RCTs, and two cross-sectional studies. Mental health benefits were consistent, with moderate-to-large reductions in stress (four studies; d=0.27-0.94), anxiety and depression (three studies; d=0.48-1.88), and improvements in well-being and resilience (four studies; d=0.32-0.78). Physiological outcomes demonstrated enhanced heart rate variability (one study; p=0.01-0.02), reduced inflammation and metabolic markers (two studies; p<0.02), and microbiome shifts (one study; padj=0.001). Effects were dose-dependent (≥3-4 days per week) and stronger amongst experienced practitioners. Risk of bias was moderate overall; sensitivity analyses confirmed findings. Isha Yoga demonstrates promising mental health benefits and preliminary physical health benefits, with stronger effects observed in sustained practice. Methodological limitations warrant caution. Future large-scale RCTs with active comparators and biomarkers are recommended to confirm efficacy and elucidate underlying mechanisms.

  • Open Access

    Effects of Yoga Interventions on Health Outcomes in Women With Gynecological Cancers: A Systematic Review of Randomised Controlled Trials

    by Selvaraj Giridharan, Nandan M. Shanbhag, Abdulrahman Bin Sumaida, Khalid Balaraj

    Gynaecological cancers have a profound impact on women's health, with survivors often experiencing a diminished quality of life (QoL) owing to treatment-related symptoms such as fatigue, psychological distress, and cognitive impairment. Yoga, as a mind-body intervention, may offer supportive benefits, although evidence specific to this population remains limited. This systematic review synthesised randomised controlled trials (RCTs) that evaluated the effects of yoga on health outcomes in women with gynaecological cancers. In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, databases (PubMed, Scopus, Web of Science, Cochrane, and Google Scholar) were searched from inception to June 2025. Eligible RCTs included those involving adult women with gynaecological cancers, yoga interventions lasting ≥4 weeks, and outcomes such as QoL, psychological well-being, fatigue, and cognition. Risk of bias was assessed using RoB 2 (Cochrane, London, United Kingdom) (some concerns overall), and a narrative synthesis was conducted owing to heterogeneity. Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to assess the certainty of the primary outcomes. Six RCTs comprising 320 participants were included. Meditative yoga (for example, yoga nidra and pranayama) reduced anxiety and depression (P = 0.00001-0.026; narrative standardized mean difference (SMD) -0.56 (95%CI -1.01 to -0.11) for depression, GRADE: moderate) and stress (P<0.0001) in four trials. QoL improved in three trials (P=0.039-<0.05; narrative SMD ~0.3 (95% CI 0.12-0.48), GRADE: low), fatigue in two (P=0.039-<0.05; narrative SMD -1.17 (95%CI -2.16 to -0.18), GRADE: low), and cognitive function in one pilot (P=0.0007 for fluid cognition; Cohen's d=0.6, GRADE: very low). Restorative yoga showed higher adherence than vigorous forms. No adverse events were observed. Preliminary evidence suggests that yoga may enhance psychological well-being, QoL, fatigue, and cognition, which is consistent with broader oncology reviews. Larger, standardised RCTs are necessary to confirm the efficacy of this treatment and inform its integration into supportive care.


  • Open Access

    Yoga Interventions for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis - A Scoping Review

    by Selvaraj Giridharan, Mrunmai Godbole

    Background: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a debilitating multisystem disorder characterized by persistent fatigue, post-exertional malaise, cognitive impairment, and pain, while also imposing significant socioeconomic burdens. Present treatments are limited, leading to the exploration of complementary therapies, such as yoga, which may affect autonomic function, inflammation, and mental health. This study aimed to map the existing literature on yoga interventions for CFS/ME and identify study designs, interventions, outcomes, and evidence gaps. Materials and Methods: We searched PubMed, Cochrane Library, and Google Scholar from their inception to April 2025 for studies on adults with CFS/ME using yoga. The inclusion criteria encompassed any design that evaluated the effects of yoga on fatigue and its related outcomes. Data were extracted on design, participants, interventions, outcomes, and findings, with the results synthesized narratively and charted. Results: Six primary studies, primarily from a Japanese group, were included. The interventions focused on adapted isometric yoga (sitting/recumbent, 2–3 months, biweekly sessions plus home practice). In some cases, fatigue was consistently reduced with improvements in vigor, pain, depression, autonomic function, and biomarkers (e.g., tumor necrosis factor-α). Adverse events were minor and transient. To date, no qualitative or large-scale studies have been conducted. Conclusions: Adapted isometric yoga shows promise in reducing fatigue in CFS/ME; however, evidence is limited by small samples, single-group designs, and short follow-ups. Larger multicenter randomized controlled studies with standardized protocols and biomarkers are needed to confirm the efficacy and guide its clinical use.

  • Open Access

    The Impact of Vipassana Meditation on Health and Well-Being: A Systematic Review of Current Evidence

    by Selvaraj Giridharan, Soni Soumian, Nagaraj V. Kumar, Mrunmai Godbole, Nagaraj V. Kumar Sr.

    Vipassana meditation, an ancient Buddhist-derived practice that emphasises insight through non-judgmental observation of sensations and thoughts, has gained popularity for its potential to enhance health and well-being. Building on earlier research, this updated review synthesises empirical evidence published since 2010 to evaluate the impact of Vipassana across the psychological, physiological, neurobiological, and behavioural domains, addressing the growing need for effective, evidence-based approaches to global mental health challenges. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, databases such as PubMed, Cochrane Library, Google Scholar, PsycINFO, and Scopus were searched from January 2010 to April 2025 to identify relevant studies. Eligible studies comprised randomized controlled trials (RCTs), single-arm trials, pilot studies, and observational designs published in English, involving adult participants and quantifiable outcomes. Reviews, non-Vipassana practices, and low-quality studies with fewer than 10 participants per group were excluded, while the risk of bias was assessed using the Cochrane Risk of Bias (RoB) 2 tool and Newcastle-Ottawa Scale. Given the heterogeneity, the findings were synthesised narratively, exploring subgroups based on retreat intensity and practitioner experience. Eleven studies were included (three RCTs, two single-arm trials, one pilot trial, and five observational trials), revealing psychological outcomes such as reductions in stress and anxiety alongside gains in mindfulness and well-being; physiological and neurobiological findings included improved hippocampal topology, increased heart rate variability, and fewer migraine days; and behavioural improvements encompassed enhanced executive functions and memory consolidation, with stronger effects noted in intensive retreats and among experienced meditators, although evidence was limited by small sample sizes, moderate to high risk of bias, and absence of blinding. In conclusion, moderate evidence supports the benefits of Vipassana meditation for psychological and physiological health, particularly in alleviating stress, anxiety, and migraine burden while enhancing mindfulness and neurobiological markers, with effects appearing intensity-dependent and retreats yielding sustained advantages. Despite methodological limitations, Vipassana holds promise as an adjunct for stress-related disorders, warranting larger, well-controlled RCTs to substantiate its long-term efficacy.


  • Open Access

    Effects of Yoga in Parkinson’s Disease: A Systematic Review of Randomized Controlled Trials

    by Selvaraj Giridharan, Jawaher Ansari, Hari Pannerselvam, Mrunmai Godbole

    Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms that diminish the quality of life (QoL). While pharmacological interventions target dopamine deficiencies, they often fail to address non-motor symptoms such as anxiety and depression. Yoga, a mind– body practice that includes posture, breathing techniques, and meditation, has gained recognition as a promising complementary therapy. This systematic review synthesized randomized controlled trials (RCTs) to assess the impact of yoga on motor and non-motor symptoms, QoL, and safety in PD patients. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram guidelines, we searched PubMed, Embase, Cochrane Library, Scopus, and Web of Science for RCTs published between January 2020 and April 2025. The inclusion criteria were adult participants with idiopathic PD, yoga as the primary intervention, and comparisons with active or passive control groups. The outcomes assessed included motor function, non-motor symptoms (e.g., anxiety and depression), QoL, and adverse events. The risk of bias was evaluated using the Cochrane Risk of Bias 2 tool, and evidence certainty was appraised using the Grading of Recommendations Assessment, Development, and Evaluation approach. Due to heterogeneity, a narrative synthesis was conducted. Results: Seven RCTs, involving 475 participants with mild-to-moderate PD, analyzed hatha or mindfulness yoga interventions over 6–12 weeks. The findings showed that yoga significantly improved motor symptoms with moderate to-large effect sizes. Studies have reported improvements in balance, although the gait effects were inconsistent. For non-motor outcomes, anxiety, and depression showed moderate reductions, while QoL improvements lasted for 6 months. Evidence indicates improvements in biomarkers such as interleukin-6. Yoga was safe with no serious adverse events. Evidence certainty was moderate for motor and non-motor outcomes. Conclusion: Yoga is a safe and feasible adjunct for PD, offering benefits for motor function, mood, and QoL. Larger, standardized RCTs with longer follow-up periods are needed to confirm and optimize protocols.


  • Open Access

    Effects of Yoga Nidra on Physical, Mental, and Emotional Health Outcomes: A Systematic Review of Randomized Controlled Trials

    by Selvaraj Giridharan, Bhuvana Pandiyan, Mrunmai Godbole

    Background: Yoga Nidra, a guided relaxation practice that originated in ancient Indian traditions, facilitates profound relaxation while maintaining awareness. Despite increasing interest in its benefits for physical, mental, and emotional health, previous reviews have often incorporated combined interventions, thereby diluting evidence regarding its standalone effects. This systematic review synthesized randomized controlled trials (RCTs) evaluating isolated Yoga Nidra to address these gaps. Materials and Methods: A systematic search was conducted across databases, including PubMed, Embase, Cochrane, Scopus, Web of Science, and PsycINFO, from inception to April 2025. Eligible RCTs included adults with health conditions, standalone Yoga Nidra interventions, and comparators. Two reviewers screened the studies, extracted data, and assessed bias using RoB 2. A narrative synthesis outlined the physical, mental, and emotional outcomes, while heterogeneity precluded a meta-analysis. Subgroup/sensitivity analyses and GRADE certainty ratings were also performed. Results: Fifteen RCTs were included to address hypertension, stress, insomnia, and menstrual disorders. The physical benefits included reductions in blood pressure and improvements in heart rate variability in 10 studies. The mental outcomes indicated a decrease in anxiety and depression in 11 studies. Emotional enhancement was observed in six studies. No adverse events were reported; RoB was low in four studies, with some concerns in 11. Conclusion: This systematic review demonstrated that Yoga Nidra exerts a positive influence on physical, mental, and emotional health, with a particular emphasis on reducing anxiety. Despite the limitations posed by study heterogeneity, Yoga Nidra has emerged as a promising evidence-based approach to health promotion. Rigorous and diverse RCTs are necessary to confirm long-term effects and expand the application of integrative care.


  • Open Access

    Maximizing Recovery: The Superiority of Frequent Vacations for Well-Being and Performance

    by Selvaraj Giridharan, Bhuvana Pandiyan

    In contemporary high-pressure work environments, strategic vacation practices are essential for maintaining employee health and productivity. This editorial examines recent research suggesting that frequent short vacations are more effective than infrequent longer breaks in sustaining well-being. We emphasise how regular vacations facilitate recovery and enhance well-being, thereby reducing stress and improving performance. We advocate the integration of frequent breaks into the workplace culture through practical strategies for both individuals and organisations. This analysis calls for researchers, practitioners, and policymakers to reconsider vacation planning and explore the advantages of more frequent vacations.

  • Open Access

    Yoga as an Adjunct Intervention for Chemotherapy-Induced Peripheral Neuropathy: Evidence, Challenges, and Future Directions

    by Selvaraj Giridharan, Mrunmai Godbole

    Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent complication of cancer treatment that causes sensory symptoms and emotional distress that impair the quality of life (QOL). Current treatments often fall short, necessitating innovative adjunct interventions. Yoga, which combines mindful movement, breathwork, and meditation, offers a holistic approach to mitigating the physical and psychosocial burdens of CIPN. Early trials suggest that yoga may reduce pain, enhance functionality, and support psychological well-being, although they are limited by small samples and inconsistent methods. Barriers to adoption include clinician skepticism, access challenges, and various research protocols. Prioritizing large-scale standardized trials, qualitative research on patient experiences, and telehealth delivery can strengthen yoga’s evidence base and accessibility. Multidisciplinary care models integrating yoga can transform CIPN management and promote patient-centered recovery in oncology.


  • Open Access

    Effects of Yoga on Gene Expression: A Systematic Review of Randomised Controlled Trials

    by Selvaraj Giridharan, Soni Soumian, Nagaraj V. Kumar, Jawaher Ansari, Nagaraj V. Kumar Sr.

    Yoga, an integrative mind-body practice, is increasingly recognised for its ability to modulate gene expression, particularly that of genes associated with inflammation, stress, and aging. This systematic review, conducted per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, synthesises evidence from 11 randomised controlled trials (RCTs) from 2015 to 2024, involving over 700 adults. Studies were sourced from PubMed, Scopus, Web of Science, and the Cochrane Library to evaluate the molecular effects and clinical implications of yoga. Across these RCTs, yoga consistently downregulated pro-inflammatory genes - interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), and nuclear factor kappa B (NF-κB) - in five studies, and upregulated anti-inflammatory and immune-regulatory genes - transforming growth factor-beta (TGF-β), forkhead box P3 (FoxP3), soluble human leukocyte antigen G (sHLA-G), and IL-10 - in four studies. It also enhanced the expression of genes linked to deoxyribonucleic acid (DNA) repair (OGG1, or 8-oxoguanine DNA glycosylase), mitochondrial function (adenosine monophosphate-activated protein kinase (AMPK), and sirtuin 1 (SIRT-1)), and epigenetic regulation (e.g., reduced TNF methylation and increased microRNA-133B (miR-133B)). These molecular changes were associated with clinical benefits, including reduced disease activity in rheumatoid arthritis (RA), improved glycemic control in type 2 diabetes (T2D), and improved quality of life among breast cancer survivors. Despite these promising findings, the small sample sizes and short intervention durations limit statistical power and generalisability. Yoga shows potential as a complementary therapy for managing inflammation and age-related conditions, but larger, longer-term RCTs with standardised protocols are essential to substantiate its therapeutic value and elucidate its mechanisms.


  • Open Access

    Advancing Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion-Mutated Non-small Cell Lung Cancer (NSCLC) Management Through Molecular Diagnostics and Targeted Therapies

    by Selvaraj Giridharan, Jawaher Ansari, Imran Hussain

    Non-small cell lung cancer (NSCLC) associated with epidermal growth factor receptor (EGFR) mutations has experienced notable therapeutic advancements; however, exon 20 insertion mutations continue to pose a significant challenge, demonstrating resistance to conventional EGFR inhibitors. Recent progress in molecular diagnostics and targeted therapies has introduced new research opportunities for NSCLC with EGFR exon 20 insertion mutations. Randomized controlled trials have shown that therapies, such as amivantamab, exhibit substantial efficacy, with combination strategies offering even greater potential. These advancements are underpinned by advanced diagnostic techniques, including next-generation sequencing and liquid biopsy, which enable precise mutation detection and real-time treatment monitoring. Nonetheless, challenges remain, including the management of toxicity, equitable access to therapies, and the need for comprehensive real-world data. Emerging therapies and innovative trial designs suggest a promising future for the management of NSCLC with EGFR exon 20 insertion mutations. This editorial examines how clinical trials and molecular diagnostics are advancing the management of EGFR exon 20 insertion-mutated NSCLC.